Intrinsiqq
Aldeyra Therapeutics Inc. logo

Aldeyra Therapeutics Inc. Insider Trading

ALDX

Compare
Cluster buy

3 insiders bought 140K of their own stock in 2 days.

Open-market purchases by executives and directors between Nov 11 and Nov 12. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+663K
6 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 12, 2026

Get an email when ALDX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 12
    Darlene M Deptula-Hicks
    Director · bought 7,500 at $0.65
    5K
    New position
  • Nov 11
    Michael Alfieri
    Principal Financial Officer · bought 10,000 at $0.65
    7K
    133% of stake
  • Nov 11
    Richard Douglas
    Director · bought 200,000 at $0.64
    129K
    103% of stake
  • Jun 3
    Todd C Brady
    President and CEO · bought 250,000 at $1.67
    418K
    17% of stake
  • Mar 19
    Richard Douglas
    Director · bought 70,000 at $1.40
    98K
    56% of stake
  • Mar 18
    Michael Alfieri
    Principal Financial Officer · bought 5,000 at $1.42
    7K
    200% of stake
  • Aug 13, 2025
    Michael Alfieri
    Principal Financial Officer · bought 2,500 at $5.30
    13K
    New position
  • Aug 11, 2025No plan
    Stephen Machatha
    Chief Development Officer · sold 22,073 at $5.15
    114K
    9.1% of stake
  • Apr 3, 2025No plan
    Perceptive Life Sciences Master Fund LTD
    Large holder · sold 3,400,000 at $1.42
    $4.83M
    37% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ALDX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ALDX

CompareIntrinsic value
ELTXElicio Therapeutics Inc.
$1.45-3.33%25
TENXTenax Therapeutics Inc.
$1.29-7.55%10
IXHLIncannex Healthcare Inc.
$1.86+6.90%10
CRMDCorMedix Inc.
$5.27+3.74%84
TOVXTheriva Biologics, Inc.
$0.12-7.69%20
IMNNImunon, Inc.
$0.54-6.05%10
GRCEGrace Therapeutics Inc.
$1.71-1.16%40
SGMTSagimet Biosciences Inc.
$9.12-5.20%10

Held by ETFs

ALDX is in 2 US ETFs. The largest of them, with ALDX's weight in each:

Spot a number that looks wrong? Check it in ALDX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ALDX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.